Examkin

Soru

Zorluk: ZorPharmacologic Interventions

A 32-year-old man is brought to the emergency department by ambulance due to a generalized tonic-clonic seizure. His partner reports that the abnormal movements started 20 minutes ago and have been continuous without any periods of responsiveness. He has no known medical history. Initial vital signs include a blood pressure of 145/85 mm Hg, heart rate of 118/min, and oxygen saturation of 94% on room air. No medications were administered en route. Two large-bore peripheral intravenous lines are immediately established in the resuscitation bay. Arrange the following pharmacologic interventions in the evidence-based sequence for the escalating management of status epilepticus, from initial abortive therapy to the treatment of super-refractory cases.

  1. 1Administer intravenous lorazepam.
  2. 2Administer intravenous fosphenytoin.
  3. 3Initiate continuous intravenous propofol infusion.
  4. 4Initiate continuous intravenous pentobarbital infusion.

Cevap

The correct sequence for the pharmacologic escalation in status epilepticus is: 1) Intravenous lorazepam, 2) Intravenous fosphenytoin, 3) Intravenous propofol infusion, 4) Intravenous pentobarbital infusion.
The American Epilepsy Society treatment algorithm for status epilepticus involves a strict step-wise escalation. Phase 1 (0-10 minutes) requires a rapid-acting benzodiazepine such as intravenous lorazepam to abort the seizure. Phase 2 (10-30 minutes) utilizes a non-anesthetic antiepileptic drug such as intravenous fosphenytoin to achieve sustained control and prevent recurrence. Phase 3 (30-60 minutes) addresses refractory status epilepticus using continuous infusions of general anesthetics like propofol or midazolam. Finally, Phase 4 addresses super-refractory status epilepticus (seizures persisting >24 hours despite anesthetics) with deep barbiturate coma using agents like pentobarbital.

Adım Adım Çözüm

1
Identify the patient's presentation as generalized convulsive status epilepticus.
The patient has had continuous seizures for 20 minutes, which meets the criteria for status epilepticus (continuous seizure >5 minutes), requiring immediate protocolized pharmacological escalation.
Prompt recognition is essential to initiate the correct time-dependent treatment algorithm and prevent permanent neuronal injury.
2
Determine the first-line (Phase 1) abortive therapy.
Intravenous lorazepam is the initial drug of choice.
Benzodiazepines enhance GABA-A receptor inhibition and are the most effective agents for rapidly terminating ongoing seizure activity.
3
Determine the second-line (Phase 2) stabilization therapy.
Intravenous fosphenytoin is administered next.
If seizures continue after adequate doses of benzodiazepines, a long-acting non-anesthetic antiepileptic drug is required to establish sustained seizure control.
4
Determine the third-line (Phase 3) therapy for refractory status epilepticus.
Continuous intravenous propofol infusion is the next appropriate step.
When seizures are refractory to Phase 1 and 2 agents, continuous anesthetic infusions are necessary to suppress cortical activity, often requiring intubation for airway protection.
5
Determine the final escalation step for super-refractory status epilepticus.
Continuous intravenous pentobarbital infusion is the last resort.
Pentobarbital induces profound burst suppression and is reserved for cases that fail to respond to other anesthetic infusions due to its significant risk of hemodynamic instability and immunosuppression.

Anahtar Kavram

The step-wise pharmacologic management of status epilepticus progresses sequentially through initial benzodiazepines, long-acting non-anesthetic antiepileptic drugs, continuous anesthetic infusions, and finally barbiturate coma for super-refractory cases.
Tahmini Süre:1m 30s
Bu soruyu puanla

Konular

Pharmacologic Interventions

Bu konudan daha fazla soru